Breast Cancer Diagnostics Market

Breast Cancer Diagnostics Market Analysis by Test Type (CA Tests, BRCA Test, ER & PR Test, CEA Test, KRAS Mutation Test, HER 2 Test, PSA Test, EGFR Mutation Test, Immunohistochemistry for Breast Cancer), by End-User & Region - Global Forecast 2022-2032

Analysis of Breast Cancer Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

Chapter 1 Global Breast Cancer Diagnostics Market - Executive Summary

Chapter 2 Global Breast Cancer Diagnostics Market Overview

2.1 Introduction

    2.1.1 Global Breast Cancer Diagnostics Market Taxonomy

    2.1.2 Global Breast Cancer Diagnostics Market Definition

2.2 Global Breast Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2017-2032

    2.2.1 Global Breast Cancer Diagnostics Market Y-o-Y Growth

2.3 Global Breast Cancer Diagnostics Market Dynamics

    2.3.1 Drivers

    2.3.2 Restraints

    2.3.3 Trends

2.4 Supply Chain

2.5 Epidemiology

2.6 List of Distributors

2.7 Average Pricing Analysis

2.8 Regulations

2.9 Key Participants Market Presence (Intensity Map) By Region

Chapter 3 Global Breast Cancer Diagnostics Market Analysis and Forecast By Test Type

3.1 Global Breast Cancer Diagnostics Market Size and Forecast By Test Type, 2017-2032

    3.1.1 BRCA Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.1.1 Revenue (US$ Mn) Comparison, By Region

          3.1.1.2 Market Share Comparison, By Region

          3.1.1.3 Y-o-Y growth Comparison, By Region

    3.1.2 ER & PR Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.2.1 Revenue (US$ Mn) Comparison, By Region

          3.1.2.2 Market Share Comparison, By Region

          3.1.2.3 Y-o-Y growth Comparison, By Region

    3.1.3 CEA Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.3.1 Revenue (US$ Mn) Comparison, By Region

          3.1.3.2 Market Share Comparison, By Region

          3.1.3.3 Y-o-Y growth Comparison, By Region

    3.1.4 KRAS Mutation Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.4.1 Revenue (US$ Mn) Comparison, By Region

          3.1.4.2 Market Share Comparison, By Region

          3.1.4.3 Y-o-Y growth Comparison, By Region

    3.1.5 HER 2 Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.5.1 Revenue (US$ Mn) Comparison, By Region

          3.1.5.2 Market Share Comparison, By Region

          3.1.5.3 Y-o-Y growth Comparison, By Region

    3.1.6 PSA Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.6.1 Revenue (US$ Mn) Comparison, By Region

          3.1.6.2 Market Share Comparison, By Region

          3.1.6.3 Y-o-Y growth Comparison, By Region

    3.1.7 CA Test Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.7.1 Revenue (US$ Mn) Comparison, By Region

          3.1.7.2 Market Share Comparison, By Region

          3.1.7.3 Y-o-Y growth Comparison, By Region

    3.1.8 EGFR Mutation Test Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.8.1 Revenue (US$ Mn) Comparison, By Region

          3.1.8.2 Market Share Comparison, By Region

          3.1.8.3 Y-o-Y growth Comparison, By Region

    3.1.9 Immunohistochemistry Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.9.1 Revenue (US$ Mn) Comparison, By Region

          3.1.9.2 Market Share Comparison, By Region

          3.1.9.3 Y-o-Y growth Comparison, By Region

    3.1.10 Others Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          3.1.10.1 Revenue (US$ Mn) Comparison, By Region

          3.1.10.2 Market Share Comparison, By Region

          3.1.10.3 Y-o-Y growth Comparison, By Region

Chapter 4 Global Breast Cancer Diagnostics Market Analysis and Forecast By End User

4.1 Global Breast Cancer Diagnostics Market Size and Forecast By End User, 2017-2032

    4.1.1 Hospital Associated Labs Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          4.1.1.1 Revenue (US$ Mn) Comparison, By Region

          4.1.1.2 Market Share Comparison, By Region

          4.1.1.3 Y-o-Y growth Comparison, By Region

    4.1.2 Independent Diagnostic Laboratories Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          4.1.2.1 Revenue (US$ Mn) Comparison, By Region

          4.1.2.2 Market Share Comparison, By Region

          4.1.2.3 Y-o-Y growth Comparison, By Region

    4.1.3 Cancer Research Institutes Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          4.1.3.1 Revenue (US$ Mn) Comparison, By Region

          4.1.3.2 Market Share Comparison, By Region

          4.1.3.3 Y-o-Y growth Comparison, By Region

    4.1.4 Others Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          4.1.4.1 Revenue (US$ Mn) Comparison, By Region

          4.1.4.2 Market Share Comparison, By Region

          4.1.4.3 Y-o-Y growth Comparison, By Region

Chapter 5 Global Breast Cancer Diagnostics Market Analysis and Forecast By Region

5.1 Global Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    5.1.1 North America Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          5.1.1.1 Revenue (US$ Mn) Comparison, By Test Type

          5.1.1.2 Revenue (US$ Mn) Comparison, By End User

    5.1.2 Latin America Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          5.1.2.1 Revenue (US$ Mn) Comparison, By Test Type

          5.1.2.2 Revenue (US$ Mn) Comparison, By End User

    5.1.3 Europe Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          5.1.3.1 Revenue (US$ Mn) Comparison, By Test Type

          5.1.3.2 Revenue (US$ Mn) Comparison, By End User

    5.1.4 Japan Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          5.1.4.1 Revenue (US$ Mn) Comparison, By Test Type

          5.1.4.2 Revenue (US$ Mn) Comparison, By End User

    5.1.5 APEJ Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          5.1.5.1 Revenue (US$ Mn) Comparison, By Test Type

          5.1.5.2 Revenue (US$ Mn) Comparison, By End User

    5.1.6 MEA Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

          5.1.6.1 Revenue (US$ Mn) Comparison, By Test Type

          5.1.6.2 Revenue (US$ Mn) Comparison, By End User

Chapter 6 North America Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032

6.1 US Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    6.1.1 Revenue (US$ Mn) Comparison, By Test Type

    6.1.2 Revenue (US$ Mn) Comparison, By End User

6.2 Canada Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    6.2.1 Revenue (US$ Mn) Comparison, By Test Type

    6.2.2 Revenue (US$ Mn) Comparison, By End User

Chapter 7 Latin America Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032

7.1 Brazil Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    7.1.1 Revenue (US$ Mn) Comparison, By Test Type

    7.1.2 Revenue (US$ Mn) Comparison, By End User

7.2 Mexico Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    7.2.1 Revenue (US$ Mn) Comparison, By Test Type

    7.2.2 Revenue (US$ Mn) Comparison, By End User

7.3 Argentina Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    7.3.1 Revenue (US$ Mn) Comparison, By Test Type

    7.3.2 Revenue (US$ Mn) Comparison, By End User

Chapter 8 Europe Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032

8.1 Germany Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    8.1.1 Revenue (US$ Mn) Comparison, By Test Type

    8.1.2 Revenue (US$ Mn) Comparison, By End User

8.2 UK Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    8.2.1 Revenue (US$ Mn) Comparison, By Test Type

    8.2.2 Revenue (US$ Mn) Comparison, By End User

8.3 France Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    8.3.1 Revenue (US$ Mn) Comparison, By Test Type

    8.3.2 Revenue (US$ Mn) Comparison, By End User

8.4 Spain Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    8.4.1 Revenue (US$ Mn) Comparison, By Test Type

    8.4.2 Revenue (US$ Mn) Comparison, By End User

8.5 Italy Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    8.5.1 Revenue (US$ Mn) Comparison, By Test Type

    8.5.2 Revenue (US$ Mn) Comparison, By End User

8.6 Nordic Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    8.6.1 Revenue (US$ Mn) Comparison, By Test Type

    8.6.2 Revenue (US$ Mn) Comparison, By End User

Chapter 9 Japan Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032

9.1 Japan Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    9.1.1 Revenue (US$ Mn) Comparison, By Test Type

    9.1.2 Revenue (US$ Mn) Comparison, By End User

Chapter 10 APEJ Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032 116

10.1 China Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    10.1.1 Revenue (US$ Mn) Comparison, By Test Type

    10.1.2 Revenue (US$ Mn) Comparison, By End User

10.2 India Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    10.2.1 Revenue (US$ Mn) Comparison, By Test Type

    10.2.2 Revenue (US$ Mn) Comparison, By End User

10.3 Malaysia Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    10.3.1 Revenue (US$ Mn) Comparison, By Test Type

    10.3.2 Revenue (US$ Mn) Comparison, By End User

10.4 Thailand Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    10.4.1 Revenue (US$ Mn) Comparison, By Test Type

    10.4.2 Revenue (US$ Mn) Comparison, By End User

10.5 Singapore Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    10.5.1 Revenue (US$ Mn) Comparison, By Test Type

    10.5.2 Revenue (US$ Mn) Comparison, By End User

10.6 Australia Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    10.6.1 Revenue (US$ Mn) Comparison, By Test Type

    10.6.2 Revenue (US$ Mn) Comparison, By End User

Chapter 11 MEA Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2032

11.1 GCC Countries Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    11.1.1 Revenue (US$ Mn) Comparison, By Test Type

    11.1.2 Revenue (US$ Mn) Comparison, By End User

11.2 South Africa Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    11.2.1 Revenue (US$ Mn) Comparison, By Test Type

    11.2.2 Revenue (US$ Mn) Comparison, By End User

11.3 Nigeria Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    11.3.1 Revenue (US$ Mn) Comparison, By Test Type

    11.3.2 Revenue (US$ Mn) Comparison, By End User

11.4 Israel Breast Cancer Diagnostics Market Size and Forecast, 2017-2032

    11.4.1 Revenue (US$ Mn) Comparison, By Test Type

    11.4.2 Revenue (US$ Mn) Comparison, By End User

Chapter 12 Company Profiles

12.1 Abbott Laboratories

    12.1.1 Company Overview

    12.1.2 Product Overview:

    12.1.3 Key Financials:

    12.1.4 SWOT Analysis

    12.1.5 Key Developments

12.2 Roche Holding AG.

    12.2.1 Company Overview

    12.2.2 Product Overview:

    12.2.3 Key Financials:

    12.2.4 Key Developments

12.3 Thermo Fisher Scientific Inc.

    12.3.1 Company Overview

    12.3.2 Product Overview:

    12.3.3 Key Financials:

    12.3.4 SWOT Analysis

    12.3.5 Key Developments

12.4 Siemens AG

    12.4.1 Company Overview

    12.4.2 Product Overview:

    12.4.3 Key Financials:

    12.4.4 SWOT Analysis

    12.4.5 Key Developments

12.5 Bio-Rad Laboratories, Inc.

    12.5.1 Company Overview

    12.5.2 Product Overview:

    12.5.3 SWOT Analysis

    12.5.4 Key Developments

12.6 Illumina, Inc. 150

    12.6.1 Company Overview

    12.6.2 Product Overview:

    12.6.3 Key Financials:

    12.6.4 SWOT Analysis

12.6.5 Key Development

12.7 Biocept, Inc.

    12.7.1 Company Overview

    12.7.2 Product Overview:

    12.7.3 Key Financials

    12.7.4 Key Developments

12.8 AstraZeneCA plc

    12.8.1 Company Overview

    12.8.2 Product Overview:

    12.8.3 Key Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

12.9 Myriad Genetics Inc

    12.9.1 Company Overview

    12.9.2 Product Overview

    12.9.3 Key Financials

    12.9.4 SWOT Analysis

12.10 Quest Diagnostics Incorporated

    12.10.1 Company Overview

    12.10.2 Product Overview

    12.10.3 Key Financials

    12.10.4 SWOT Analysis

Chapter 13 Disclaimer and Contact information

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

TABLE 1: Global Breast Cancer Diagnostics Market Value (US$ Mn), 2017-2021

TABLE 2: Global Breast Cancer Diagnostics Market Value (US$ Mn), 2022-2032

TABLE 3: Global Breast Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2017-2032 Value (US$ Mn)

TABLE 4: Global BRCA Segment Value (US$ Mn), By Region 2017-2021

TABLE 5: Global BRCA Segment Value (US$ Mn), By Region 2022-2032

TABLE 6: Global BRCA Segment Market Share, By Region 2017-2021

TABLE 7: Global BRCA Segment Market Share, By Region 2022-2032

TABLE 8: Global BRCA Segment Y-o-Y, By Region 2017-2032

TABLE 9: Global ER & PR Segment Value (US$ Mn), By Region 2017-2021

TABLE 10: Global ER & PR Segment Value (US$ Mn), By Region 2022-2032

TABLE 11: Global ER & PR Segment Market Share, By Region 2017-2021

TABLE 12: Global ER & PR Segment Market Share, By Region 2022-2032

TABLE 13: Global ER & PR Segment Y-o-Y, By Region 2017-2032

TABLE 14: Global CEA Segment Value (US$ Mn), By Region 2017-2021

TABLE 15: Global CEA Segment Value (US$ Mn), By Region 2022-2032

TABLE 16: Global CEA Segment Market Share, By Region 2017-2021

TABLE 17: Global CEA Segment Market Share, By Region 2022-2032

TABLE 18: Global CEA Segment Y-o-Y, By Region 2017-2032

TABLE 19: Global KRAS Mutation Segment Value (US$ Mn), By Region 2017-2021

TABLE 20: Global KRAS Mutation Segment Value (US$ Mn), By Region 2022-2032

TABLE 21: Global KRAS Mutation Segment Market Share, By Region 2017-2021

TABLE 22: Global KRAS Mutation Segment Market Share, By Region 2022-2032

TABLE 23: Global KRAS Mutation Segment Y-o-Y, By Region 2017-2032

TABLE 24: Global HER 2 Segment Value (US$ Mn), By Region 2017-2021

TABLE 25: Global HER 2 Segment Value (US$ Mn), By Region 2022-2032

TABLE 26: Global HER 2 Segment Market Share, By Region 2017-2021

TABLE 27: Global HER 2 Segment Market Share, By Region 2022-2032

TABLE 28: Global HER 2 Segment Y-o-Y, By Region 2017-2032

TABLE 29: Global PSA Segment Value (US$ Mn), By Region 2017-2021

TABLE 30: Global PSA Segment Value (US$ Mn), By Region 2022-2032

TABLE 31: Global PSA Segment Market Share, By Region 2017-2021

TABLE 32: Global PSA Segment Market Share, By Region 2022-2032

TABLE 33: Global PSA Segment Y-o-Y, By Region 2017-2032

TABLE 34: Global CA Test Segment Value (US$ Mn), By Region 2017-2021

TABLE 35: Global CA Test Segment Value (US$ Mn), By Region 2022-2032

TABLE 36: Global CA Test Segment Market Share, By Region 2017-2021

TABLE 37: Global CA Test Segment Market Share, By Region 2022-2032

TABLE 38: Global CA Test Segment Y-o-Y, By Region 2017-2032

TABLE 39: Global EGFR Mutation Test Segment Value (US$ Mn), By Region 2017-2021

TABLE 40: Global EGFR Mutation Test Segment Value (US$ Mn), By Region 2022-2032

TABLE 41: Global EGFR Mutation Test Segment Market Share, By Region 2017-2021

TABLE 42: Global EGFR Mutation Test Segment Market Share, By Region 2022-2032

TABLE 43: Global EGFR Mutation Test Segment Y-o-Y, By Region 2017-2032

TABLE 44: Global Immunohistochemistry Segment Value (US$ Mn), By Region 2017-2021

TABLE 45: Global Immunohistochemistry Segment Value (US$ Mn), By Region 2022-2032MEA

TABLE 46: Global Immunohistochemistry Segment Market Share, By Region 2017-2021

TABLE 47: Global Immunohistochemistry Segment Market Share, By Region 2022-2032

TABLE 48: Global Immunohistochemistry Segment Y-o-Y, By Region 2017-2032

TABLE 49: Global Others Segment Value (US$ Mn), By Region 2017-2021

TABLE 50: Global Others Segment Value (US$ Mn), By Region 2022-2032

TABLE 51: Global Others Segment Market Share, By Region 2017-2021

TABLE 52: Global Others Segment Market Share, By Region 2022-2032

TABLE 53: Global Others Segment Y-o-Y, By Region 2017-2032

TABLE 54: Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2017-2021

TABLE 55: Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2022-2032

TABLE 56: Global Hospital Associated Labs Segment Market Share, By Region 2017-2021

TABLE 57: Global Hospital Associated Labs Segment Market Share, By Region 2022-2032

TABLE 58: Global Hospital Associated Labs Segment Y-o-Y, By Region 2017-2032

TABLE 59: Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2017-2021

TABLE 60: Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2022-2032

TABLE 61: Global Independent Diagnostic Laboratories Segment Market Share, By Region 2017-2021

TABLE 62: Global Independent Diagnostic Laboratories Segment Market Share, By Region 2022-2032

TABLE 63: Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2017-2032

TABLE 64: Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2017-2021

TABLE 65: Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2022-2032

TABLE 66: Global Cancer Research Institutes Segment Market Share, By Region 2017-2021

TABLE 67: Global Cancer Research Institutes Segment Market Share, By Region 2022-2032

TABLE 68: Global Cancer Research Institutes Segment Y-o-Y, By Region 2017-2032

TABLE 69: Global Others Segment Value (US$ Mn), By Region 2017-2021

TABLE 70: Global Others Segment Value (US$ Mn), By Region 2022-2032

TABLE 71: Global Others Segment Market Share, By Region 2017-2021

TABLE 72: Global Others Segment Market Share, By Region 2022-2032

TABLE 73: Global Others Segment Y-o-Y, By Region 2017-2032

TABLE 74: North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 75: North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 76: North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 77: North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 78: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 79: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 80: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 81: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 82: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 83: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 84: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 85: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 86: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 87: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 88: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 89: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 90: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 91: Source: FactMR, 2021APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 92: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 93: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 94: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 95: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 96: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 97: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 98: US Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 99: US Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 100: US Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 101: US Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 102: Canada Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 103: Canada Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 104: Canada Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 105: Canada Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 106: Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 107: Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 108: Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 109: Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 110: Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 111: Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 112: Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 113: Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 114: Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 115: Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 116: Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 117: Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 118: Germany Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 119: Germany Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 120: Germany Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 121: Germany Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 122: UK Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 123: UK Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 124: UK Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 125: UK Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 126: France Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 127: France Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 128: France Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 129: France Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 130: Spain Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 131: Spain Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 132: Spain Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 133: Spain Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 134: Italy Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 135: Italy Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 136: Italy Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 137: Italy Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 138: Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 139: Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 140: Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 141: Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 142: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 143: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 144: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 145: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 146: China Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 147: China Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 148: China Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 149: China Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 150: India Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 151: India Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 152: India Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 153: India Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 154: Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 155: Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 156: Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 157: Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 158: Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 159: Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 160: Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 161: Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 162: Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 163: Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 164: Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 165: Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 166: Australia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 167: Australia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 168: Australia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 169: Australia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 170: GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 171: GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 172: GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 173: GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 174: South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 175: South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 176: South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 177: South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 178: Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 179: Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 180: Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 181: Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

TABLE 182: Israel Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

TABLE 183: Israel Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

TABLE 184: Israel Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

TABLE 185: Israel Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

FIG. 1: Global Breast Cancer Diagnostics Market Value (US$ Mn), 2017-2021: Global Breast Cancer Value), 2022-2032 Value (US$ Mn)

FIG. 2: Breast Cancer Diagnostics Market Value (US$ Mn) Forecast, 2022-2032

FIG. 3: Global Breast Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2017-2032

FIG. 4: Global BRCA Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 5: Global BRCA Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 6: Global BRCA Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 7: Global ER & PR Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 8: Global ER & PR Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 9: Global ER & PR Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 10: Global CEA Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 11: Global CEA Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 12: Global CEA Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 13: Global KRAS Mutation Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 14: Global KRAS Mutation Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 15: Global KRAS Mutation Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 16: Global HER 2 Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 17: Global HER 2 Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 18: Global HER 2 Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 19: Global PSA Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 20: Global PSA Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 21: Global PSA Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 22: Global CA Test Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 23: Global CA Test Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 24: Global CA Test Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 25: Global EGFR Mutation Test Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 26: Global EGFR Mutation Test Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 27: Global EGFR Mutation Test Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 28: Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 29: Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 30: Global Immunohistochemistry Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 31: Global Others Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 32: Global Others Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 33: Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 34: Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 35: Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 36: Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 37: Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 38: Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 39: Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 40: Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 41: Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 42: Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2017-2032

FIG. 43: Global Others Segment Market Value (US$ Mn) By Region, 2017-2021

FIG. 44: Global Others Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 45: Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031

FIG. 46: North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

FIG. 47: North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

FIG. 48: North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

FIG. 49: North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

FIG. 50: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

FIG. 51: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

FIG. 52: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

FIG. 53: Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

FIG. 54: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

FIG. 55: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

FIG. 56: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

FIG. 57: Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

FIG. 58: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

FIG. 59: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

FIG. 60: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

FIG. 61: Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

FIG. 62: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

FIG. 63: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

FIG. 64: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

FIG. 65: APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

FIG. 66: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2021

FIG. 67: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032

FIG. 68: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2021

FIG. 69: MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Breast Cancer Diagnostics Market

Schedule a Call